Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2110530 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B | |
| SCHEMBL7264535 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B | |
| SCHEMBL2112303 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B | |
| SCHEMBL7259740 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B | |
| SCHEMBL10383717 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B | |
| SCHEMBL7265188 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B | |
| SCHEMBL7264534 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B | |
| SCHEMBL2108217 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B | |
| SCHEMBL93119 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B | |
| SCHEMBL7265217 | 1.00 | FAAH (0.43) | FAAHCNR1CNR2MAPTADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1903069-B1 | NOVEL POLYMER AND METHOD OF MEASURING CHOLESTEROL THEREWITH | WAKO PURE CHEM IND LTD (JP) | 2015-08-12 | — | — | EP | disclosed |
| EP-2821395-A2 | Novel disulfonic acid ester as an additive for an electrolyte for a lithium secondary battery | Wako Pure Chemical Industries, Ltd. (JP) | 2015-01-07 | — | — | EP | disclosed |
| US-8716513-B2 | Process for production of bis-quaternary ammonium salt, and novel intermediate | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2014-05-06 | — | — | US | disclosed |
| EP-2463266-A1 | PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | Wako Pure Chemical Industries, Ltd. (JP) | 2012-06-13 | — | — | EP | disclosed |
| US-20120130107-A1 | PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
| US-8158375-B2 | Polymer and method of measuring cholesterol therewith | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-17 | — | — | US | disclosed |
| EP-2239281-A2 | Novel polymer and method for determining cholesterol using the same | Wako Pure Chemical Industries, Ltd. (JP) | 2010-10-13 | — | — | EP | disclosed |
| US-20090215097-A1 | Novel Polymer and Method of Measuring Cholesterol Therewith | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-08-27 | — | — | US | disclosed |
| EP-1903069-A1 | NOVEL POLYMER AND METHOD OF MEASURING CHOLESTEROL THEREWITH | Wako Pure Chemical Industries, Ltd. (JP) | 2008-03-26 | — | — | EP | disclosed |
| US-6645671-B2 | Suppressing reaction between organic solvent and anode via imide compound which coordinates with lithium ions quickly and strongly, improving cycling; power sources for memory retention in electronics | FUJITSU LIMITED (JP) | 2003-11-11 | — | — | US | disclosed |
| EP-1158589-A1 | SECONDARY LITHIUM BATTERY, NEGATIVE ELECTRODE FOR SECONDARY LITHIUM BATTERY, AND PROCESS FOR PRODUCING THE NEGATIVE ELECTRODE | FUJITSU LIMITED (JP) | 2001-11-28 | — | — | EP | disclosed |
| US-20010031396-A1 | Lithium secondary battery, anode for lithium secondary battery, and method for manufacturing the anode | FUJITSU LIMITED (JP) | 2001-10-18 | — | — | US | disclosed |
| US-5998065-A | N-OXYIMIDE ADDITIVE | FUJITSU LIMITED (JP) | 1999-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120130107-A1 | PROCESS FOR PRODUCTION OF BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | ASS1, C1S, FHIT | FAAH 477/4885CNR1 1779/4885CNR2 2401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.